ARTELO BIOSCIENCES, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
ARTELO BIOSCIENCES, INC. (ARTL) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $1.02 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-03-25
- ARTELO BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2019-05-31 was $39.74K.
- ARTELO BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2019-02-28 was $29.30K.
- ARTELO BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2018-11-30 was $28.05K.
- ARTELO BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $1.02M, a 58.50% decline from fiscal 2022.
- ARTELO BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $2.46M.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.02M 10-K · filed 2024-03-25 | |||
| 2022-12-31 | $2.46M 10-K · filed 2024-03-25 | |||
| 2019-05-31 | $39.74K 10-Q · filed 2020-07-13 | $69.04K derived: sum of 2 quarters · filed 2020-07-13 | $97.09K derived: sum of 3 quarters · filed 2020-07-13 | |
| 2019-02-28 | $29.30K 10-Q · filed 2020-07-13 | $57.35K derived: sum of 2 quarters · filed 2020-07-13 | ||
| 2018-11-30 | $28.05K 10-Q · filed 2020-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |